This content requires the Adobe Flash Player.
Get Flash
09 Mar 2010 17:22
Tate & Lyle PLC Directorate Change
Tate & Lyle PLC announces today that Douglas Hurt has been appointed as a Non-Executive Director with effect from 10 March 2010.
Douglas Hurt is Finance Director of IMI plc, the listed international engineering group. Prior to joining IMI plc in 2006, he held a number of financial and operational roles, including US and European senior management positions, at GlaxoSmithKline. He is a member of the Institute of Chartered Accountants.
Sir Peter Gershon, Chairman of Tate & Lyle, said "The Board is delighted that Douglas has agreed to join us. His financial and business management experience will be of great benefit to the Board.”
There are no further disclosures to be made in connection with Mr Hurt’s appointment pursuant to paragraph 9.6.13 of the Financial Services Authority’s Listing Rules.
For more information contact:
Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, operating from more than 45 production facilities around the world. Through our large-scale, efficient manufacturing plants, we turn raw materials into distinctive, high quality ingredients for our customers. Our ingredients and solutions add taste, texture, nutrition and increased functionality to products that millions of people around the world use or consume every day.
Tate & Lyle’s range of leading branded food ingredients includes SPLENDA® Sucralose, PROMITOR™ Dietary Fiber and STA-LITE® Polydextrose. Tate & Lyle also produces branded industrial ingredients including Bio-PDO™, Ethylex® and Sta-Lok® paper starches; and staple ingredients such as high fructose corn syrup, ethanol, citric acid and basic starches. In addition to providing a wide range of ingredients our Innovation and Commercial Development Group supports customers by providing product development, technical advice and proprietary consumer insight studies.
Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2010, Tate & Lyle employed 5,666 people in its subsidiaries and joint ventures, and sales totalled £3.50 billion. http://www.tateandlyle.com.
SPLENDA® is a trademark of McNeil Nutritionals, LLC